How we remove cells, debris, and large particulates from the production bioreactor effluent using depth filtration and/or centrifugation.
Welcome back to our deep‑dive series on monoclonal antibody manufacturing. In Step 3, we completed a 14–21 day fed‑batch production run. The bioreactor now contains a complex mixture: our monoclonal antibody (secreted into the medium), viable and dead CHO cells, cellular debris, host cell proteins (HCPs), DNA, media components, and metabolic byproducts.
This turbid, particle‑laden fluid is called Harvested Cell Culture Fluid (HCCF) . Before we can purify the antibody using Protein A chromatography, we must remove the cells and large debris. That is the job of Step 4: Harvest and Clarification.
If we skip or underperform this step, the downstream purification train will suffer from fouled columns, high pressure, low flow rates, and ultimately, failed batches. Let’s walk through the process, equipment, and critical considerations.
Overview: What Is Clarification?
Clarification is a physical separation process that removes suspended solids (cells, debris, aggregates) from the liquid phase containing the dissolved mAb. The output is a low‑turbidity, particle‑free fluid ready for Protein A capture.
Two primary technologies dominate the industry:
Depth filtration – used alone for smaller scales (up to 2,000 L) or as a polishing step after centrifugation.
Centrifugation + depth filtration – the standard for commercial scales (10,000–25,000 L), combining high throughput with fine polishing.
For this post, we will describe the centrifugation + depth filtration train, which is typical for a product like Humira.
Step 4.1: Bioreactor Transfer and Pretreatment
Objective: Move the HCCF from the production bioreactor to the harvest system while maintaining sterility and product stability.
Process:
Cool the bioreactor (if possible) to 4–15°C. Lower temperature slows cell metabolism, reduces proteolysis, and minimizes product aggregation.
Adjust pH if needed – some processes lower pH to 4.5–5.0 to inactivate proteases and kill residual cells, but this must be compatible with the mAb’s stability.
Transfer using a low‑shear pump (peristaltic or diaphragm) through sterile tubing to a hold tank (chilled, agitated) or directly to the centrifuge.
Critical parameters:
Transfer time: As short as possible (typically <4 hours) to prevent cell lysis.
Temperature: Maintain 4–15°C throughout harvest.
Equipment:
Chilled hold tank (500–5,000 L) with gentle agitation (e.g., stainless steel with jacket)
Low‑shear transfer pump (e.g., Watson‑Marlow 800 series peristaltic, or Alfa Laval LKH centrifugal with VFD)
Sanitary tubing and aseptic connectors
Step 4.2: Primary Clarification – Centrifugation
Objective: Remove the bulk of cells and large debris, reducing the solid load for the subsequent depth filters.
The industry standard for large‑scale mAb harvest is the disk‑stack centrifuge.
How a Disk‑Stack Centrifuge Works
The HCCF enters a rapidly spinning bowl (4,000–10,000 × g).
Solids (cells, debris) are forced outward against the bowl wall and discharged intermittently (or continuously).
The clarified liquid (centrate) exits through the top and flows to the next stage.
Two discharge modes:
| Mode | Description | Best for |
|---|---|---|
| Nozzle discharge | Continuous solids ejection through nozzles | High cell density (>20 × 10⁶ cells/mL) |
| Intermittent discharge (self‑cleaning) | Periodic opening of the bowl to eject accumulated solids | Typical fed‑batch (10–30 × 10⁶ cells/mL) |
Process settings for mAb harvest:
Feed rate: 500–5,000 L/h (scale‑dependent)
Bowl speed: 6,000–10,000 rpm (depending on model)
Centrate turbidity target: <100 NTU (nephelometric turbidity units)
Solids discharge interval: Every 15–60 minutes
Performance: Centrifugation alone typically removes 95–99% of cells but leaves fine particles (<1–5 µm) and colloids. The centrate still has a hazy appearance.
Equipment:
Disk‑stack centrifuge (e.g., GEA Westfalia CSA, Alfa Laval Foodec or Brewster, Flottweg AC series)
CIP skid for cleaning the centrifuge bowl and housing
Solids collection tank (for waste cell paste)
Step 4.3: Secondary Clarification – Depth Filtration
Objective: Remove remaining fine particles, colloids, and some HCPs/DNA to achieve a clear filtrate suitable for Protein A chromatography (turbidity typically <10 NTU, ideally <5 NTU).
Depth filters are non‑sterile, disposable cartridges made of cellulose fibers, diatomaceous earth (perlite), and a binding resin. They capture particles throughout the filter matrix, not just on the surface.
Typical Depth Filter Train (3 stages)
| Stage | Nominal Pore Size | Function |
|---|---|---|
| Primary (coarse) | 8–10 µm | Remove large aggregates and any remaining whole cells |
| Secondary (medium) | 2–5 µm | Remove smaller debris and colloids |
| Polishing (fine) | 0.2–1 µm | Reduce turbidity to <5 NTU; may include a charge‑modified membrane to bind DNA and endotoxins |
Process:
Set up a filter housing containing the three stages in series (pre‑sterilized, single‑use capsules or stainless steel housings with disposable cartridges).
Pre‑flush with buffer or WFI to remove manufacturing residues.
Pump the centrate through the depth filters at a constant flow rate (e.g., 50–200 L/m²/h, known as the flux).
Monitor pressure – as pores clog, differential pressure (ΔP) increases. Stop when ΔP reaches the filter manufacturer’s limit (typically 2–3 bar) or when the target volume is processed.
Collect the clarified filtrate in a sterile, chilled hold tank.
Key performance indicators:
Filter throughput (L/m²) – target depends on cell density and debris load. Typical: 100–500 L/m².
Turbidity of filtrate – <5 NTU is excellent.
Recovery – >95% of mAb (some product may bind to filter media).
Equipment:
Depth filter capsules or cartridges (e.g., Millipore Millistak+ HC, Pall Supracap, Sartorius Sartoclear)
Filter housing (single‑use or stainless steel, e.g., Sartorius Sartopress, Pall SupraPak)
Pressure gauges (inlet, outlet) and flowmeter
Peristaltic or diaphragm pump
Step 4.4: Post‑Clarification Hold and Stabilization
The clarified HCCF (now often called Clarified Bulk Harvest or Protein A Load) is not yet stable. It still contains HCPs, DNA, and media components that can degrade the product if held too long.
Hold conditions:
Temperature: 2–8°C (cold room or jacketed tank)
Duration: Typically <24–48 hours before Protein A capture
Additives: Some processes add a protease inhibitor (e.g., PMSF) or EDTA to chelate metal‑dependent proteases.
Testing before Protein A:
Turbidity (<5 NTU)
Bioburden (<1 CFU/10 mL)
Endotoxin (<1 EU/mL – depends on downstream capacity)
pH (record, adjust if necessary)
Step 4.5: Process Integration and Automation
In a modern manufacturing facility, the harvest train is automated:
SCADA/DCS controls centrifuge start/stop, feed rate, bowl speed, discharge cycles.
Pressure sensors on depth filters trigger an alarm or switch to a parallel filter train when ΔP is high.
Turbidity meters (in‑line) ensure product quality before Protein A.
Single‑use vs. stainless steel:
Single‑use depth filters are dominant for clinical and commercial scales up to 2,000 L. For 20,000 L, stainless steel housings with disposable cartridges are common.
Single‑use centrifuges are emerging (e.g., Centritech, Secor), but disk‑stack centrifuges remain mostly stainless steel due to the mechanical forces.
What Can Go Wrong? (Troubleshooting Step 4)
| Problem | Possible Cause | Remedy |
|---|---|---|
| Low centrifuge recovery (<90%) | Bowl speed too low; feed rate too high; solids discharge too frequent | Optimize settings; reduce feed rate; increase discharge interval |
| High turbidity after centrifugation | Incomplete solids discharge; centrifuge overloaded | Check nozzle/discharge; reduce feed density (dilute with buffer) |
| Rapid depth filter clogging | High cell debris load; cells lysed before harvest | Harvest earlier (before viability drops); add flocculant (e.g., chitosan) |
| Poor turbidity after depth filters | Filter pore size too large; filter channeling | Use finer polishing filter; check housing seals |
| mAb loss on depth filters (>5%) | Hydrophobic binding or charge interaction | Pre‑condition filters with product buffer; choose low‑binding cellulose grades |
| High bioburden in clarified harvest | Contamination during transfer; inadequate CIP/SIP | Sterilize all lines and tanks; sample and test; discard if contaminated |
Emerging Alternatives and Intensifications
While centrifugation + depth filtration is the industry standard, new technologies are gaining ground:
Flocculation: Adding cationic polymers (e.g., polydiallyldimethylammonium chloride, pDADMAC) or precipitating agents (e.g., caprylic acid) to aggregate cells and debris, allowing direct depth filtration without centrifugation.
Tangential flow microfiltration (TFF-MF): Using hollow fiber or flat‑sheet membranes (0.1–0.2 µm) to continuously remove cells while retaining product in the permeate. Used in perfusion processes.
Acoustic wave separation: Using standing ultrasound waves to aggregate cells for sedimentation (e.g., BioSep, Applikon). Still niche for mAbs.
For a legacy fed‑batch process like Humira, however, disk‑stack centrifuge plus depth filters remains the reliable workhorse.
What Comes Next?
The clarified, particle‑free HCCF is now ready for the most powerful purification step in the entire train: Protein A Affinity Chromatography. This single step captures the antibody with >95% purity and concentrates it 10‑ to 100‑fold.
That will be Step 5: Protein A Capture Chromatography – covering column packing, equilibration, loading, washing, elution, and cleaning‑in‑place (CIP).
The text above is owned by the site above referred.
Here is only a small part of the article, for more please follow the link
Also see:
Manostaxx – Industrial Management Consulting
